Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: August 29, 2016
Reporting Period: Unaudited interim condensed consolidated financial statements as of June 30, 2016.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. It references attached exhibits (99.1 and 99.2) which contain the Operating and Financial Review and the Unaudited Interim Condensed Consolidated Financial Statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Detailed comparisons are contained within the referenced exhibits.
Guidance, Outlook, and Risks
The filing incorporates by reference an "Operating and Financial Review and Prospects" (Exhibit 99.1). However, the text of the Form 6-K itself does not summarize specific guidance, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Review Exhibit 99.1 for the detailed Operating and Financial Review and Prospects.
- Analyze Exhibit 99.2 for the specific unaudited interim condensed consolidated financial statements as of June 30, 2016.
- Verify the incorporation by reference into Registration Statements on Form F-3 (File Nos. 333-195124, 333-199033, 333-204795, and 333-209037).
- Confirm the company's status as a foreign private issuer filing under Form 20-F.